Yale Medical Group announces a new core leadership group

As the practice grows, each member will manage a key area

Michael Berman, MD

As Yale Medical Group (YMG) continues to grow as a practice, Interim Executive Director Michael Berman, MD, has restructured the core leadership team with the appointment of six administrators who report directly to him—and who will report to a new executive director once that person is hired.

“Our practice has grown to a point where we really need to focus on specialization as far as how we approach the day-to-day operations of our practice,” Dr. Berman said. “We have a number of key areas of our business that need to be addressed. We need a leadership team in which each person can develop and focus his or her special expertise in a key area.”

Dr. Berman included the following administrators on his leadership team:

Daniel Barchi continues to serve as chief information officer for YMG and Yale New Haven Health System. Barchi oversees all information systems and information technology, including the development of new applications. He also directs all of YMG’s medical informatics programs and is developing a new reporting and analytics group that will work with the leadership team, and departmental chairs and administrators, on support management scorecards to enable departmental and institutional decision-making.

Fred Borrelli assumes the role of chief operating officer of YMG, while continuing to serve as associate chair and chief of administration for the Department of Surgery. As COO, Borrelli will work to improve and standardize YMG’s clinical operations. He will launch critical initiatives focused on reducing the cost of practice, elevating the patient experience, optimizing clinical space utilization, and integrating new physicians and acquired practices into YMG. Borrelli will also be responsible for providing practice management services at the Yale Physicians Building with the goal of establishing and maintaining a high-performing clinical operation.

Carrie Capezzone continues to serve as a key leader in Yale School of Medicine Finance, while assuming an expanded role as the chief financial officer of YMG. Capezzone will assume responsibility for practice strategic financial planning and other initiatives, including practice acquisition costing/financial planning and analysis. She will be the liaison on behalf of the practice for managed care contracting services.

Marianne Dess-Santoro now directs YMG’s revenue cycle as chief revenue officer. She will also focus her leadership on two critical initiatives: the Epic conversion for professional billings and the revenue cycle optimization project with Huron Consulting. The revenue cycle project has the potential to improve cash collections substantially across the practice.

Karin Render continues to serve as director of strategic planning and development. She will be instrumental in establishing an enhanced Strategic Planning & Institutional Services group, which will provide strategy development, program planning, physician recruitment, performance improvement and performance analytics services.

Ronald Vender, MD, continues to serve as the associate dean for clinical affairs and chief medical officer, a post he was appointed to in 2008. He is the executive sponsor of the Epic project and will collaborate with the Epic team, Fred Borrelli and departments on optimizing ongoing operations and workflow. Dr. Vender will continue to be responsible for YMG’s medical affairs/services, patient safety, clinical quality, risk management, credentialing, physician relations, CME and HIPAA/privacy services.